Reporting owner · Q3 2026 · CIK 1555952

5AM Partners II, LLC: insider trades.

5AM Partners II, LLC reported 15 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 15 sales ($445K), across 1 company.

Transactions
15
Purchases (P)
0
Sales (S)
15
Companies
1
Name as filed
5AM Partners II, LLC

Companies

CompanyRelationshipTransactions
Skye Bioscience, Inc. (SKYE)TenPercentOwner15

Transactions

15 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-23Skye Bioscience, Inc.S4,528$1.610Form 4
2026-09-23Skye Bioscience, Inc.S114,851$1.610Form 4
2026-09-22Skye Bioscience, Inc.S1,088$1.654,528Form 4
2026-09-22Skye Bioscience, Inc.S27,612$1.65114,851Form 4
2026-09-16Skye Bioscience, Inc.S1,285$1.915,616Form 4
2026-09-16Skye Bioscience, Inc.S32,607$1.91142,463Form 4
2026-08-20Skye Bioscience, Inc.S46$0.3255,208Form 4
2026-08-20Skye Bioscience, Inc.S6,495$0.327,850,155Form 4
2026-08-20Skye Bioscience, Inc.S1,159$0.321,400,560Form 4
2026-08-19Skye Bioscience, Inc.S10,255$0.351,401,719Form 4
2026-08-19Skye Bioscience, Inc.S57,476$0.357,856,650Form 4
2026-08-19Skye Bioscience, Inc.S409$0.3555,254Form 4
2026-08-18Skye Bioscience, Inc.S45,090$0.381,411,974Form 4
2026-08-18Skye Bioscience, Inc.S1,830$0.3855,663Form 4
2026-08-18Skye Bioscience, Inc.S253,080$0.387,914,126Form 4

Questions

What stock did 5AM Partners II, LLC buy or sell?

5AM Partners II, LLC reported 15 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 15 sales ($445K), across 1 company.

Is 5AM Partners II, LLC the same person as other filers with this name?

This page covers SEC CIK 1555952 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/5am-partners-ii-llc-1555952.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.